ClinicalTrials.Veeva

Menu
I

Instituto Medico Platense | Clinical Research Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Pimodivir
Ustekinumab
Ribavirin
Proxinium
INM005
Farletuzumab
Taxane
Baloxavir Marboxil
Oseltamivir
Guselkumab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 19 total trials

A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications. (RSVHR)

This is a Phase 2b, randomized, double-blind, placebo-controlled study of EDP-938 administered orally for the treatment of non-hospitalized adult sub...

Enrolling
RSV Infection
Drug: EDP-938
Drug: Placebo
Locations recently updated

The purpose of this study is to evaluate the pharmacokinetics (PK), efficacy, safety and immunogenicity of ustekinumab and guselkumab in active juven...

Enrolling
Arthritis, Juvenile
Drug: Guselkumab
Drug: Ustekinumab

Primary objective:- To evaluate the efficacy of oral reparixin versus standard care alone in limiting disease progression in adult patients hospitali...

Enrolling
Infectious Pneumonia
Severe COVID-19
Other: Placebo
Drug: Reparixin

Trial sponsors

Janssen (J&J Innovative Medicine) logo
University of Minnesota (UMN) logo
Bristol-Myers Squibb (BMS) logo
Corvus Pharmaceuticals logo
Dompé logo
Enanta Pharmaceuticals logo
Janssen (J&J Innovative Medicine) logo
Moderna logo
M
National Institute of Allergy and Infectious Diseases (NIAID) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems